Literature DB >> 10577972

Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction.

W B van den Berg1, L A Joosten, G Kollias, F A van De Loo.   

Abstract

Chronic arthritis is characterised by persistent joint inflammation and concomitant joint destruction. Using murine arthritis models and neutralising antibodies as well as cytokine specific knockout conditions, it was found that tumour necrosis factor alpha (TNFalpha) is important in early joint swelling. Membrane bound TNFalpha is sufficient to drive this aspect of inflammation as well as the acute cellular infiltrate in the synovial tissue. Interleukin 1 (IL1) is not necessarily a dominant cytokine in early joint swelling, but has a pivotal role in sustained cellular infiltration and erosive cartilage damage. TNFalpha independent IL1 production is a prominent feature in murine arthritis models. These observations provide evidence for potential uncoupling of joint inflammation and erosive changes, implying that both cytokines need to be targeted to achieve optimal treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577972      PMCID: PMC1766568          DOI: 10.1136/ard.58.2008.i40

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  47 in total

1.  Intraarticular variability of synovial membrane histology, immunohistology, and cytokine mRNA expression in patients with rheumatoid arthritis.

Authors:  B Kirkham; I Portek; C S Lee; B Stavros; A Lenarczyk; M Lassere; J Edmonds
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

Review 2.  How important are T cells in chronic rheumatoid synovitis?

Authors:  G S Firestein; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1990-06

3.  Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo.

Authors:  B Henderson; E R Pettipher
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

4.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.

Authors:  D Kontoyiannis; M Pasparakis; T T Pizarro; F Cominelli; G Kollias
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

5.  Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis.

Authors:  J B van Meurs; P L van Lent; A E Holthuysen; I I Singer; E K Bayne; W B van den Berg
Journal:  Arthritis Rheum       Date:  1999-06

6.  Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

Authors:  F M Brennan; D Chantry; A Jackson; R Maini; M Feldmann
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

7.  Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation.

Authors:  A A van de Loo; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

8.  Flare of antigen-induced arthritis in mice after intravenous challenge. Kinetics of antigen in the circulation and localization of antigen in the arthritic and noninflamed joint.

Authors:  J W Lens; W B van den Berg; L B van de Putte; W A Zwarts
Journal:  Arthritis Rheum       Date:  1986-05

9.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage.

Authors:  J Saklatvala
Journal:  Nature       Date:  1986 Aug 7-13       Impact factor: 49.962

View more
  31 in total

1.  Tumor necrosis factor alpha-dependent proinflammatory gene induction is inhibited by cyclic tensile strain in articular chondrocytes in vitro.

Authors:  P Long; R Gassner; S Agarwal
Journal:  Arthritis Rheum       Date:  2001-10

2.  Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis : a therapeutic study using a macrophage-deactivating compound.

Authors:  K Palmblad; H Erlandsson-Harris; K J Tracey; U Andersson
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Myrtol ameliorates cartilage lesions in an osteoarthritis rat model.

Authors:  Binbin Ying; Abudu Kelimujiang Maimaiti; Donghui Song; Songsong Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  Proteases for cell suicide: functions and regulation of caspases.

Authors:  H Y Chang; X Yang
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

5.  Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

Authors:  P Barrera; L A Joosten; A A den Broeder; L B van de Putte; P L van Riel; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2001-07       Impact factor: 19.103

6.  GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice.

Authors:  C Plater-Zyberk; L A B Joosten; M M A Helsen; J Hepp; P A Baeuerle; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2006-10-04       Impact factor: 19.103

7.  Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta.

Authors:  L J Sandell; X Xing; C Franz; S Davies; L-W Chang; D Patra
Journal:  Osteoarthritis Cartilage       Date:  2008-06-18       Impact factor: 6.576

8.  Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro.

Authors:  R L Van Bezooijen; L Van Der Wee-Pals; S E Papapoulos; C W G M Löwik
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

9.  A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis.

Authors:  Onno J Arntz; Jeroen Geurts; Sharon Veenbergen; Miranda B Bennink; Ben T van den Brand; Shahla Abdollahi-Roodsaz; Wim B van den Berg; Fons A van de Loo
Journal:  Arthritis Res Ther       Date:  2010-04-06       Impact factor: 5.156

Review 10.  Advances in combining gene therapy with cell and tissue engineering-based approaches to enhance healing of the meniscus.

Authors:  M Cucchiarini; A L McNulty; R L Mauck; L A Setton; F Guilak; H Madry
Journal:  Osteoarthritis Cartilage       Date:  2016-04-05       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.